$270 Million is the total value of HARBOURVEST PARTNERS LLC's 36 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TDOC | New | TelaDoc Health, Inc. | $11,169,000 | – | 50,943 | +100.0% | 4.13% | – |
| ONEM | New | 1Life Healthcare, Inc. | $9,968,000 | – | 351,480 | +100.0% | 3.69% | – |
| PGNY | New | Progyny, Inc. | $2,577,000 | – | 87,574 | +100.0% | 0.95% | – |
| NTNX | New | Nutanix, Inc. | $2,352,000 | – | 106,049 | +100.0% | 0.87% | – |
| PD | New | PagerDuty, Inc. | $1,841,000 | – | 67,891 | +100.0% | 0.68% | – |
| New | Crispr Therapeutics AGnamen akt | $1,793,000 | – | 21,439 | +100.0% | 0.66% | – | |
| CNST | New | Constellation Pharmaceuticals, Inc. | $1,005,000 | – | 49,614 | +100.0% | 0.37% | – |
| PHR | New | Phreesia, Inc. | $789,000 | – | 24,562 | +100.0% | 0.29% | – |
| VCYT | New | Veracyte, Inc. | $766,000 | – | 23,591 | +100.0% | 0.28% | – |
| ARVN | New | Arvinas, Inc. | $393,000 | – | 16,666 | +100.0% | 0.14% | – |
| BDTX | New | Black Diamond Therapeutics, Inc. | $290,000 | – | 9,581 | +100.0% | 0.11% | – |
| REAL | New | The RealReal, Inc. | $106,000 | – | 7,300 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
| Trevena, Inc. | 25 | Q4 2021 | 1.2% |
| Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
| Zuora, Inc. | 21 | Q3 2023 | 3.4% |
| Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
| CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
| LendingClub Corp. | 18 | Q3 2019 | 11.9% |
| Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
| Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
| Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
| N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
| OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
| Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
| ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
| NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
| CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
| VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 40-APP | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-26 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.